Transluminal Technologies
Syracuse, US · New York LLC
Founders & leadership
RC
Ronald CaputoExecutive
SM
Stephen M GreenExecutive
Board
DL
Denis L HarringtonBoard director
MM
Mikio MiyawakiBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 2 rounds · 2011–2013
▶$1.5MraisedApr 2020 · 27 investors · BiotechnologyRule 506(b)
▶$1.5MraisedApr 2020 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen M GreenExecutive Officer, Director
- Mikio MiyawakiDirector
- Ronald CaputoExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $25K
- Sales commissions
- $75K
- Proceeds to insiders
- $1.4M
- Placement agents
- Pinnacle Investments, Inc.
- First sale
- Aug 2011
- Incorporated
- Limited Liability Company, New York
- Federal exemptions
- 06b
▶$1.5MraisedMay 2015 · 32 investors · BiotechnologyRule 506(c)
▶$1.5MraisedMay 2015 · 32 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Ronald CaputoExecutive Officer, Director
- Denis L HarringtonDirector
- Mikio MiyawakiDirector
- Stephen M GreenExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $25K
- Sales commissions
- $75K
- Placement agents
- Sage Rutty & Co., Inc.
- First sale
- Jul 2013
- Incorporated
- Limited Liability Company, New York
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Transluminal Technologies raised?
- Transluminal Technologies has disclosed $3M raised across 2 rounds.
- Where is Transluminal Technologies headquartered?
- Transluminal Technologies is headquartered in Syracuse, US.